Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Drug Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Drug Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Drug Toxicity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...
May 2022
298 pages
Dry (Atrophic) Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Dry (Atrophic) Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Dry (Atrophic) Macular Degeneration Drugs in Development by Stages, Target,...
May 2022
103 pages
Ductal Carcinoma In Situ Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Ductal Carcinoma In Situ Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ductal Carcinoma In Situ Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
36 pages
Duodenal Ulcer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Duodenal Ulcer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Duodenal Ulcer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...
May 2022
42 pages
Dystonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Dystonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Dystonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...
May 2022
43 pages
Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Edema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview...
May 2022
44 pages
Emesis (Vomiting) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Emesis (Vomiting) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Emesis (Vomiting) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...
May 2022
48 pages
Emphysema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Emphysema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Emphysema Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...
May 2022
43 pages
Endocarditis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Endocarditis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Endocarditis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...
May 2022
35 pages
Endocrine Gland Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Endocrine Gland Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Endocrine Gland Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
52 pages
Endotoxemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Endotoxemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Endotoxemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...
May 2022
36 pages
Enteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Enteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...
May 2022
43 pages
Enterobacteriaceae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Enterobacteriaceae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enterobacteriaceae Infections Drugs in Development by Stages, Target, MoA, RoA, Mo...
May 2022
226 pages
Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA...
May 2022
84 pages
Enterococcus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Enterococcus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enterococcus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...
May 2022
99 pages
Enterovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Enterovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Enterovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...
May 2022
143 pages
Ependymoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Ependymoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ependymoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...
May 2022
56 pages
Epileptic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Epileptic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Epileptic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...
May 2022
48 pages
Epithelial Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Epithelial Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Epithelial Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...
May 2022
248 pages
Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Essential Tremor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
May 2022
48 pages
Exocrine Pancreatic Insufficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Exocrine Pancreatic Insufficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Exocrine Pancreatic Insufficiency Drugs in Development by Stages, Target, MoA,...
May 2022
36 pages
Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Extrahepatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Mo...
May 2022
51 pages
Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Familial Amyloid Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA...
May 2022
37 pages
Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,500.00
Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fatty Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
May 2022
184 pages
Febrile Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Febrile Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Febrile Neutropenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...
May 2022
47 pages
Fecal Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Fecal Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fecal Incontinence Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
May 2022
37 pages
Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
US$ 2,000.00
Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview...
May 2022
41 pages
